Dossier Evaluation status

Dossier Evaluation status

Data platform availability banner - dossier evaluation status

The new ECHA CHEM database has been released by ECHA. See for more information on the transition to ECHA CHEM.  More

Please be aware that REACH registration data on the current Dissemination Platform (accessible through the magnifying glass icon in the table) is no longer maintained; it remains frozen as of 19th May 2023. As shown in the support page we hope to move the dossier evaluation information to ECHA CHEM by the end of 2024. Until then, while the assessment status will be updated here, the corresponding registration dossiers will be available only on ECHA CHEM.

We appreciate your understanding during this transition period.


 

Dossier Evaluation status

ECHA’s dossier evaluation process covers compliance checks and the examination of testing proposals. By consulting the table below, you can find out whether ECHA has started to evaluate dossiers for a particular substance and follow the progress through the evaluation process.

The table below displays the type, scope and status of the assessment undertaken for a given dossier. The decision date and the non-confidential version of the decision are published shortly after the decision has been adopted.

Before publishing the non-confidential version of an adopted decision on its website, ECHA consults the addressees of the decision on this version. ECHA systematically removes any personal data from the non-confidential version of a decision. Some sections may also be redacted based on justified claims by registrants, regarding information confidential or deemed to harm their commercial interest if disclosed.

Check the expandable boxes below for more details.

 

Content of the table

Identifiers of the substance: Name (as on the Dissemination website); EC/List number (European Community number / List number assigned by ECHA); CAS number (also called the Chemical Abstract Service Registry Number or CAS RN).

Decision type can be ‘CCH’ for Compliance Check Evaluation and ‘TPE’ for Testing Proposal Evaluation.

Scope refers to the scope of the evaluation and can be:

  • Targeted: The compliance check focuses only on some endpoints.
  • Comprehensive: The compliance check focuses on all relevant endpoints under ECHA’s strategy.
  • Testing proposal: The assessment focuses on the testing proposals submitted by the registrants.

Status reports the current position of the dossier in the dossier evaluation process and can be:

  • Under assessment: The evaluation of the dossier has formally started.
  • Ongoing: The registrants have received the draft decision - The dossier retains this status until the decision is adopted or the evaluation is otherwise concluded.
  • Information requested: The registrants have received the adopted decision with the deadline for providing the requested information.
  • Follow-up: The deadline set in the adopted decision has passed, and ECHA is assessing whether the information requested in the decision has been provided in the dossier update - This follow-up may also involve the national enforcement authorities.
  • Concluded: The evaluation is closed.
    In most cases, this means that the registrant has responded to the adopted decision with compliant information. However, as in some cases an evaluation is concluded at an earlier stage, an adopted decision is not always available for every evaluation marked as concluded.

Decision date reports the date on which the adopted decision was sent to the registrants.

Decision displays a non-confidential version of the adopted decision once available.

Latest update indicates the date of the latest automatic update carried out by ECHA’s information systems.

Unless confidentiality is claimed on the substance identifiers, you can access the disseminated registration dossiers for the substance in ECHA CHEM. From the table below, click on the substance name link to access the Substance Infocard. From there you will find a link to direct you to the ECHA CHEM substance Dashboard and the REACH registration dossier(s). You can also go directly to ECHA CHEM and search with substance identifiers. 

The magnifying glass icon leads to information on the current dissemination platform that has not been updated since May 2023. We apologise for the inconvenience and appreciate your understanding during the transition period. 

You can access additional information in ‘Details’ view, by clicking on the eye icon:

  • Substance identifiers
  • Decision type (CCH or TPE), scope and status of the evaluation, as in the main table
  • Decision’s deadline(s): The deadline(s) for requested information contained in the decision, should the decision contain more than one deadline
  • Appeal information: If the registrants have appealed against the adopted decision, a link to the Board of Appeal’s announcement document is provided.

 

How to read the table

ECHA’s information systems automatically update the status of dossier evaluations during the process. For transparency reasons, all dossier evaluation decisions will remain published. This also applies if the registrants have appealed or have updated the registration dossier as requested in the decision.

It is for the reader to verify the status of an evaluation: check the deadline of the decision, the indicated status of the evaluation, and the content of the registration dossier. The most recent registration data on a substance is available in the ECHA CHEM database; check also whether the Board of Appeal has taken a decision regarding any appeal.

 

Important notes:

  • The dossier evaluation decisions may not apply to all registrants that are part of a joint registration.
  • There may be a delay between the decision date and the actual publication of the adopted decision, which corresponds to the consultation on its non-confidential version and addressing any comments from the registrants.
Last updated 28 March 2024. Database contains 4138 unique substances/entries.
Filter the list
Decision's deadline:
Decision date:

The List does not contain any Substances.
Decision    
946-149-3
1571954-81-8
TPE
Testing Proposal
Follow-up
05-Jul-2019
10-Nov-2023
View
Details
939-704-6
-
CCH
Comprehensive
Concluded
05-Jul-2019
26-Nov-2022
View
Details
215-691-6
1344-28-1
TPE
Testing Proposal
Follow-up
05-Jul-2019
26-Nov-2022
View
Details
202-870-9
100-61-8
TPE
Testing Proposal
Concluded
05-Jul-2019
26-Nov-2022
View
Details
269-144-1
68188-18-1
CCH
Comprehensive
Concluded
05-Jul-2019
26-Nov-2022
View
Details
201-116-6
78-42-2
CCH
Comprehensive
Follow-up
05-Jul-2019
26-Nov-2022
View
Details
426-730-3
123439-82-7
TPE
Testing Proposal
Concluded
08-Jul-2019
26-Nov-2022
View
Details
PLATINUM(2+), TETRAAMMINE-, (SP-4-1)-, DIACETATE (9CI)
457-310-8
-
TPE
Testing Proposal
Concluded
08-Jul-2019
26-Nov-2022
View
Details
237-706-5
13933-32-9
TPE
Testing Proposal
Concluded
08-Jul-2019
26-Nov-2022
View
Details
243-929-9
20634-12-2
TPE
Testing Proposal
Concluded
08-Jul-2019
26-Nov-2022
View
Details
201-244-2
80-04-6
TPE
Testing Proposal
Concluded
09-Jul-2019
26-Nov-2022
View
Details
The residuum from the reaction of diethylene glycol and ammonia. It consists predominantly of morpholine-based derivatives such as [(aminoethoxy)ethyl]morpholine, [(hydroxyethoxy)ethyl]morpholine, 3-morpholinone, and 4,4'-(oxydi-2,1-ethanediyl)bis[morpholine].
272-712-1
68909-77-3
CCH
Targeted
Concluded
22-Jul-2019
06-Dec-2022
View
Details
203-928-6
112-02-7
CCH
Comprehensive
Concluded
23-Jul-2019
26-Nov-2022
View
Details
CHIMASSORB 119; LOWILITE 19
401-990-0
106990-43-6
CCH
Comprehensive
Follow-up
23-Jul-2019
26-Nov-2022
View
Details
CHIMASSORB 119; LOWILITE 19
401-990-0
106990-43-6
CCH
Comprehensive
Follow-up
23-Jul-2019
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C16-C18 and C18 unsaturated alkyl trimethyl ammonium chloride and SDA Reporting Number: 11-045-00.
268-074-9
68002-61-9
CCH
Comprehensive
Concluded
23-Jul-2019
26-Nov-2022
View
Details
263-005-9
61788-78-1
CCH
Comprehensive
Concluded
23-Jul-2019
26-Nov-2022
View
Details
939-290-7
-
CCH
Comprehensive
Concluded
23-Jul-2019
26-Nov-2022
View
Details
939-616-8
-
CCH
Comprehensive
Concluded
23-Jul-2019
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C12-C18 dialkyl dimethyl ammonium chloride and SDA Reporting Number: 16-047-00.
269-924-1
68391-05-9
CCH
Comprehensive
Follow-up
23-Jul-2019
26-Nov-2022
View
Details
212-454-9
818-61-1
CCH
Comprehensive
Follow-up
24-Jul-2019
10-Mar-2023
View
Details
219-606-3
2478-10-6
CCH
Comprehensive
Concluded
24-Jul-2019
22-Mar-2023
View
Details
B 290; BK 400; CK 34; DIBUTYL-N-102; DX-20; FAT NR. 40391/A; FLUORAN BLACK BD 869; FLUORAN SCHWARZ BD 869; NOIR FLUORANE BD 869; ODB-2; PSD-290; SENOR-2; TG-31; TH-108; WINCON-2
403-830-5
89331-94-2
TPE
Testing Proposal
Follow-up
24-Jul-2019
10-Aug-2021
View
Details
B 290; BK 400; CK 34; DIBUTYL-N-102; DX-20; FAT NR. 40391/A; FLUORAN BLACK BD 869; FLUORAN SCHWARZ BD 869; NOIR FLUORANE BD 869; ODB-2; PSD-290; SENOR-2; TG-31; TH-108; WINCON-2
403-830-5
89331-94-2
CCH
Comprehensive
Follow-up
24-Jul-2019
09-Feb-2023
View
Details
221-111-2
3006-86-8
CCH
Comprehensive
Follow-up
24-Jul-2019
26-Nov-2022
View
Details
701-340-9
-
CCH
Comprehensive
Concluded
25-Jul-2019
26-Nov-2022
View
Details
701-186-2
-
CCH
Comprehensive
Follow-up
25-Jul-2019
26-Nov-2022
View
Details
254-911-5
40412-06-4
TPE
Testing Proposal
Concluded
08-Aug-2019
26-Nov-2022
View
Details
441-620-5
-
TPE
Testing Proposal
Follow-up
08-Aug-2019
26-Nov-2022
Details
278-770-4
77804-81-0
CCH
Comprehensive
Follow-up
19-Aug-2019
26-Nov-2022
View
Details
235-462-4
12236-62-3
CCH
Comprehensive
Follow-up
19-Aug-2019
26-Nov-2022
View
Details
250-830-4
31837-42-0
CCH
Comprehensive
Follow-up
19-Aug-2019
26-Nov-2022
View
Details
252-650-1
35636-63-6
CCH
Comprehensive
Follow-up
19-Aug-2019
26-Nov-2022
View
Details
249-955-7
29920-31-8
CCH
Comprehensive
Follow-up
19-Aug-2019
26-Nov-2022
View
Details
279-914-9
82199-12-0
CCH
Comprehensive
Follow-up
19-Aug-2019
26-Nov-2022
View
Details
258-221-5
52846-56-7
CCH
Comprehensive
Follow-up
19-Aug-2019
26-Nov-2022
View
Details
268-734-6
68134-22-5
CCH
Comprehensive
Follow-up
19-Aug-2019
26-Nov-2022
View
Details
277-873-1
74441-05-7
CCH
Comprehensive
Follow-up
19-Aug-2019
26-Nov-2022
View
Details
246-690-9
25167-70-8
TPE
Testing Proposal
Concluded
20-Aug-2019
26-Nov-2022
View
Details
223-517-5
3937-56-2
TPE
Testing Proposal
Concluded
20-Aug-2019
26-Nov-2022
View
Details
701-241-0
-
CCH
Comprehensive
Concluded
20-Aug-2019
26-Nov-2022
View
Details
946-533-0
-
TPE
Testing Proposal
Concluded
20-Aug-2019
26-Nov-2022
View
Details
205-465-5
141-17-3
CCH
Comprehensive
Concluded
26-Aug-2019
26-Nov-2022
View
Details
203-686-1
109-60-4
CCH
Targeted
Concluded
26-Aug-2019
26-Nov-2022
View
Details
268-626-9
68131-73-7
CCH
Targeted
Follow-up
02-Sep-2019
26-Nov-2022
View
Details
292-587-7
90640-66-7
CCH
Targeted
Follow-up
02-Sep-2019
26-Nov-2022
View
Details
292-588-2
90640-67-8
CCH
Targeted
Follow-up
02-Sep-2019
26-Nov-2022
View
Details
701-266-7
-
CCH
Targeted
Follow-up
02-Sep-2019
26-Nov-2022
View
Details
243-072-0
19438-60-9
TPE
Testing Proposal
Follow-up
04-Sep-2019
22-Feb-2023
View
Details
278-934-5
78521-39-8
CCH
Comprehensive
Concluded
16-Sep-2019
06-Jul-2023
View
Details
701-175-2
-
CCH
Comprehensive
Concluded
17-Sep-2019
26-Nov-2022
View
Details
217-316-1
1809-19-4
CCH
Comprehensive
Concluded
17-Sep-2019
26-Nov-2022
View
Details
432-520-2
232938-43-1
CCH
Comprehensive
Concluded
17-Sep-2019
26-Nov-2022
View
Details
926-000-9
-
CCH
Comprehensive
Follow-up
19-Sep-2019
26-Nov-2022
View
Details
202-908-4
101-02-0
CCH
Comprehensive
Concluded
19-Sep-2019
26-Nov-2022
View
Details
272-657-3
68901-15-5
TPE
Testing Proposal
Concluded
23-Sep-2019
26-Nov-2022
View
Details
701-133-3
-
TPE
Testing Proposal
Concluded
23-Sep-2019
26-Nov-2022
View
Details
271-360-6
68551-08-6
CCH
Targeted
Concluded
25-Sep-2019
26-Nov-2022
View
Details
235-790-8
12737-27-8
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
235-790-8
12737-27-8
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77347.
269-049-5
68186-87-8
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77347.
269-049-5
68186-87-8
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
701-304-2
-
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
701-304-2
-
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77005.
269-061-0
68186-99-2
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77005.
269-061-0
68186-99-2
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
An inorganic pigment that is the reaction product of high temperature calcination in which praseodymium (III) oxide, praseodymium (IV) oxide, silicon oxide, and zirconium (IV) oxide in varying amounts are homogeneously and ionically interdiffused to form a crystalline matrix of zircon. Its composition may include any one or a combination of the modifiers alkali or alkaline earth halides.
269-075-7
68187-15-5
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
An inorganic pigment that is the reaction product of high temperature calcination in which praseodymium (III) oxide, praseodymium (IV) oxide, silicon oxide, and zirconium (IV) oxide in varying amounts are homogeneously and ionically interdiffused to form a crystalline matrix of zircon. Its composition may include any one or a combination of the modifiers alkali or alkaline earth halides.
269-075-7
68187-15-5
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
283-392-8
84605-29-8
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
288-917-4
85940-28-9
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
273-527-9
68988-45-4
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
270-478-5
68442-22-8
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
272-723-1
68909-93-3
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
270-608-0
68457-79-4
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
272-238-5
68784-31-6
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
249-109-7
28629-66-5
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
234-277-6
11059-65-7
TPE
Testing Proposal
Follow-up
27-Sep-2019
04-Sep-2023
View
Details
224-235-5
4259-15-8
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
247-810-2
26566-95-0
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
298-577-9
93819-94-4
TPE
Testing Proposal
Follow-up
27-Sep-2019
04-Sep-2023
View
Details
230-257-6
6990-43-8
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
218-679-9
2215-35-2
TPE
Testing Proposal
Concluded
27-Sep-2019
26-Nov-2022
View
Details
204-065-8
115-10-6
CCH
Comprehensive
Follow-up
17-Oct-2019
09-Feb-2023
View
Details
234-364-9
11120-25-5
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
231-975-2
7783-03-1
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
236-743-4
13472-45-2
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
234-733-4
12028-48-7
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
915-093-1
-
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
231-143-9
7440-33-7
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
235-123-0
12070-12-1
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
234-842-7
12036-22-5
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
254-413-8
39318-18-8
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
215-231-4
1314-35-8
CCH
Comprehensive
Concluded
28-Oct-2019
26-Nov-2022
View
Details
260-350-7
56706-10-6
TPE
Testing Proposal
Follow-up
04-Nov-2019
26-Nov-2022
View
Details
916-899-6
-
TPE
Testing Proposal
Concluded
04-Nov-2019
26-Nov-2022
View
Details
266-564-7
67075-37-0
CCH
Comprehensive
Follow-up
08-Nov-2019
26-Nov-2022
View
Details
225-590-9
4948-15-6
CCH
Comprehensive
Follow-up
08-Nov-2019
26-Nov-2022
View
Details
280-472-4
83524-75-8
CCH
Comprehensive
Follow-up
08-Nov-2019
26-Nov-2022
View
Details
221-264-5
3049-71-6
CCH
Comprehensive
Follow-up
08-Nov-2019
26-Nov-2022
View
Details
226-866-1
5521-31-3
CCH
Comprehensive
Follow-up
08-Nov-2019
26-Nov-2022
View
Details
270-112-4
68411-27-8
CCH
Targeted
Concluded
08-Nov-2019
31-Mar-2023
View
Details
201-344-6
81-33-4
CCH
Comprehensive
Follow-up
08-Nov-2019
26-Nov-2022
View
Details
222-852-4
3634-83-1
CCH
Comprehensive
Concluded
13-Nov-2019
26-Nov-2022
View
Details
MR-8A; MR-N2; NBDI
411-280-2
74091-64-8
CCH
Comprehensive
Follow-up
13-Nov-2019
26-Nov-2022
View
Details
701-204-9
-
CCH
Comprehensive
Follow-up
13-Nov-2019
26-Nov-2022
View
Details
209-406-4
577-11-7
CCH
Comprehensive
Concluded
14-Nov-2019
26-Nov-2022
View
Details
941-224-7
-
CCH
Comprehensive
Information requested
14-Nov-2019
09-Feb-2023
View
Details
204-839-5
127-39-9
CCH
Comprehensive
Information requested
14-Nov-2019
09-Feb-2023
View
Details
219-147-9
2373-38-8
CCH
Comprehensive
Information requested
14-Nov-2019
09-Feb-2023
View
Details
245-629-3
23386-52-9
CCH
Comprehensive
Information requested
14-Nov-2019
09-Feb-2023
View
Details
249-894-6
29857-13-4
CCH
Comprehensive
Information requested
14-Nov-2019
09-Feb-2023
View
Details
259-515-6
55184-72-0
CCH
Comprehensive
Concluded
14-Nov-2019
26-Nov-2022
View
Details
238-270-9
14324-55-1
TPE
Testing Proposal
Concluded
14-Nov-2019
19-Jan-2023
View
Details
629-715-1
1226892-43-8
CCH
Comprehensive
Follow-up
15-Nov-2019
26-Nov-2022
View
Details
200-820-0
74-89-5
CCH
Comprehensive
Concluded
15-Nov-2019
26-Nov-2022
View
Details
251-156-3
32687-78-8
CCH
Comprehensive
Follow-up
22-Nov-2019
26-Nov-2022
View
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
TPE
Testing Proposal
Follow-up
22-Nov-2019
26-Nov-2022
View
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
CCH
Comprehensive
Follow-up
22-Nov-2019
26-Nov-2022
View
Details
233-050-9
10025-99-7
TPE
Testing Proposal
Concluded
22-Nov-2019
26-Nov-2022
View
Details
245-442-7
23128-74-7
CCH
Comprehensive
Follow-up
22-Nov-2019
26-Nov-2022
View
Details
255-392-8
41484-35-9
CCH
Comprehensive
Follow-up
22-Nov-2019
26-Nov-2022
View
Details
911-811-2
-
CCH
Comprehensive
Follow-up
04-Dec-2019
26-Nov-2022
View
Details
939-513-8
-
CCH
Comprehensive
Follow-up
04-Dec-2019
25-Oct-2023
View
Details
701-230-0
-
CCH
Comprehensive
Concluded
09-Dec-2019
26-Nov-2022
View
Details
205-861-8
156-62-7
TPE
Testing Proposal
Concluded
09-Dec-2019
26-Nov-2022
View
Details
700-903-6
255830-15-0
TPE
Testing Proposal
Concluded
09-Dec-2019
26-Nov-2022
View
Details
201-073-3
77-98-5
TPE
Testing Proposal
Concluded
09-Dec-2019
26-Nov-2022
View
Details
701-247-3
-
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
233-215-5
10081-67-1
CCH
Comprehensive
Concluded
10-Dec-2019
12-Oct-2023
View
Details
202-691-6
98-67-9
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
943-024-5
-
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
202-638-7
98-11-3
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
240-210-1
16066-35-6
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
629-764-9
164524-02-1
TPE
Testing Proposal
Follow-up
10-Dec-2019
06-Jan-2023
View
Details
629-764-9
164524-02-1
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
701-037-1
-
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
239-854-6
15763-76-5
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
239-854-6
15763-76-5
TPE
Testing Proposal
Follow-up
10-Dec-2019
06-Jan-2023
View
Details
211-522-5
657-84-1
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
211-522-5
657-84-1
TPE
Testing Proposal
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
203-180-0
104-15-4
CCH
Comprehensive
Follow-up
10-Dec-2019
26-Nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-016-2
9004-98-2
CCH
Comprehensive
Follow-up
11-Dec-2019
09-Feb-2023
View
Details
1 - 2.5 moles ethoxylated
500-457-0
160901-19-9
CCH
Comprehensive
Follow-up
11-Dec-2019
26-Nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-213-3
68439-50-9
CCH
Comprehensive
Follow-up
11-Dec-2019
26-Nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-195-7
68131-39-5
CCH
Comprehensive
Follow-up
11-Dec-2019
26-Nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-236-9
68920-66-1
CCH
Comprehensive
Follow-up
11-Dec-2019
26-Nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-446-0
160901-09-7
CCH
Comprehensive
Follow-up
11-Dec-2019
26-Nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-014-1
9004-95-9
CCH
Comprehensive
Follow-up
11-Dec-2019
26-Nov-2022
View
Details
200-624-5
66-25-1
TPE
Testing Proposal
Follow-up
11-Dec-2019
26-Nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-017-8
9005-00-9
CCH
Comprehensive
Follow-up
11-Dec-2019
26-Nov-2022
View
Details
701-012-5
2449089-78-3
TPE
Testing Proposal
Concluded
12-Dec-2019
26-Nov-2022
View
Details
240-973-0
16919-58-7
TPE
Testing Proposal
Concluded
12-Dec-2019
26-Nov-2022
View
Details
240-979-3
16921-30-5
TPE
Testing Proposal
Concluded
12-Dec-2019
26-Nov-2022
View
Details
241-010-7
16941-12-1
TPE
Testing Proposal
Concluded
12-Dec-2019
26-Nov-2022
View
Details
236-050-7
13122-18-4
CCH
Comprehensive
Follow-up
12-Dec-2019
26-Nov-2022
View
Details
247-955-1
26748-41-4
CCH
Comprehensive
Follow-up
12-Dec-2019
09-Feb-2023
View
Details
213-147-2
927-07-1
CCH
Comprehensive
Follow-up
12-Dec-2019
09-Feb-2023
View
Details
236-948-9
13560-89-9
CCH
Comprehensive
Follow-up
13-Dec-2019
26-Nov-2022
View
Details
203-940-1
112-15-2
CCH
Comprehensive
Follow-up
13-Dec-2019
26-Nov-2022
View
Details
203-940-1
112-15-2
CCH
Comprehensive
Follow-up
13-Dec-2019
26-Nov-2022
View
Details
627-872-0
1514-82-5
CCH
Comprehensive
Concluded
13-Dec-2019
26-Nov-2022
View
Details
204-445-3
121-03-9
CCH
Comprehensive
Follow-up
13-Dec-2019
06-Jan-2023
View
Details
268-859-6
68152-93-2
TPE
Testing Proposal
Follow-up
13-Dec-2019
26-Nov-2022
View
Details
268-859-6
68152-93-2
CCH
Comprehensive
Concluded
13-Dec-2019
01-Jun-2023
View
Details
204-402-9
120-51-4
CCH
Comprehensive
Concluded
10-Jan-2020
26-Nov-2022
View
Details
800-940-9
35836-72-7
CCH
Comprehensive
Follow-up
13-Jan-2020
26-Nov-2022
View
Details
237-331-7
13749-61-6
CCH
Comprehensive
Follow-up
13-Jan-2020
26-Nov-2022
View
Details
940-877-5
-
TPE
Testing Proposal
Concluded
13-Jan-2020
26-Nov-2022
View
Details
269-212-0
68201-32-1
CCH
Comprehensive
Follow-up
03-Feb-2020
26-Nov-2022
View
Details
923-900-3
-
CCH
Comprehensive
Follow-up
03-Feb-2020
26-Nov-2022
View
Details
238-778-0
14726-36-4
CCH
Targeted
Concluded
03-Feb-2020
30-Jan-2023
View
Details
205-232-8
136-23-2
CCH
Targeted
Follow-up
03-Feb-2020
26-Nov-2022
View
Details
293-878-1
91648-19-0
CCH
Comprehensive
Follow-up
05-Feb-2020
26-Nov-2022
View
Details
293-878-1
91648-19-0
TPE
Testing Proposal
Concluded
05-Feb-2020
26-Nov-2022
View
Details
228-055-8
6104-30-9
CCH
Targeted
Concluded
05-Feb-2020
26-Nov-2022
View
Details
441-570-4
-
TPE
Testing Proposal
Follow-up
05-Feb-2020
14-Aug-2023
View
Details
600-809-4
1072-53-3
TPE
Testing Proposal
Follow-up
06-Feb-2020
26-Nov-2022
View
Details
201-177-9
79-10-7
CCH
Comprehensive
Concluded
06-Feb-2020
26-Nov-2022
Details
207-312-8
461-58-5
CCH
Comprehensive
Follow-up
06-Feb-2020
26-Nov-2022
View
Details
451-620-7
352230-22-9
TPE
Testing Proposal
Follow-up
06-Feb-2020
26-Nov-2022
View
Details
948-040-6
-
TPE
Testing Proposal
Concluded
06-Feb-2020
26-Nov-2022
View
Details
246-678-3
25155-25-3
TPE
Testing Proposal
Concluded
07-Feb-2020
23-Mar-2023
View
Details
247-118-0
25584-83-2
CCH
Targeted
Concluded
07-Feb-2020
13-Sep-2023
View
Details
276-014-8
71786-60-2
TPE
Testing Proposal
Follow-up
07-Feb-2020
26-Nov-2022
View
Details
271-846-8
68609-97-2
CCH
Targeted
Concluded
07-Feb-2020
15-Feb-2024
View
Details
618-561-0
-
CCH
Comprehensive
Concluded
07-Feb-2020
26-Nov-2022
View
Details
814-509-8
62132-67-6
TPE
Testing Proposal
Follow-up
10-Feb-2020
26-Nov-2022
View
Details
245-509-0
23235-61-2
CCH
Comprehensive
Concluded
10-Feb-2020
26-Nov-2022
View
Details
204-794-1
126-58-9
CCH
Comprehensive
Concluded
10-Feb-2020
26-Nov-2022
View
Details
203-988-3
112-59-4
CCH
Comprehensive
Follow-up
10-Feb-2020
26-Nov-2022
View
Details
219-785-8
2530-85-0
TPE
Testing Proposal
Follow-up
10-Feb-2020
26-Nov-2022
View
Details
601-601-6
119345-04-9
CCH
Comprehensive
Follow-up
10-Feb-2020
23-Aug-2023
View
Details
601-601-6
119345-04-9
TPE
Testing Proposal
Follow-up
10-Feb-2020
24-May-2023
View
Details
701-279-8
1931129-39-3
TPE
Testing Proposal
Follow-up
10-Feb-2020
26-Nov-2022
View
Details
215-149-9
1306-25-8
CCH
Comprehensive
Follow-up
10-Feb-2020
26-Nov-2022
View
Details
219-702-5
2500-88-1
CCH
Comprehensive
Follow-up
10-Feb-2020
26-Nov-2022
View
Details
202-870-9
100-61-8
CCH
Comprehensive
Follow-up
10-Feb-2020
26-Nov-2022
View
Details
220-260-0
2691-41-0
CCH
Comprehensive
Concluded
10-Feb-2020
26-Nov-2022
View
Details
204-500-1
121-82-4
CCH
Comprehensive
Concluded
10-Feb-2020
26-Nov-2022
View
Details
938-572-7
-
TPE
Testing Proposal
Concluded
10-Feb-2020
14-Mar-2024
View
Details

Export search results to: